Bottom line
SDAAX vs PRUFX: the short answer
SDAAX (Swan Defined Risk Growth Fund) and PRUFX (T. Rowe Price Growth Stock Fund, Inc.) are both mutual funds.
But PRUFX is far broader, holding 115 positions to 20 for SDAAX, so beyond the top names it adds exposure SDAAX doesn't have.
PRUFX is cheaper at 0.52% vs 1.68% — a difference of $116 a year per $10,000 invested.
Over five years, PRUFX returned +9.5% a year vs +7.8% for SDAAX.
SDAAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
SDAAX vs PRUFX side by side
| SDAAX | PRUFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | T. Rowe Price |
| Category | Large Growth | Large Growth |
| Expense ratio | 1.68% | 0.52% |
| Annual cost per $10k | $168 | $52 |
| 10-yr cost on $10k (prospectus) | $2,465 | $653 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +7.6% | +15.8% |
| 5-yr return (annualized) | +7.8% | +9.5% |
| 10-yr return (annualized) | — | +14.3% |
| Best quarter | +13.8% | +27.7% |
| Worst quarter | −14.6% | −25.4% |
| Net assets (fund) | $59.2M | $50.1B |
| Number of holdings | 20 | 115 |
| Portfolio turnover | 14% | 35% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
SDAAX and PRUFX share none of their top holdings.
SDAAX top 10
- Ishares Trust — 89.83%
- N/a — 5.82%
- N/a — 2.34%
- First American Funds Inc — 1.85%
- N/a — 1.78%
- N/a — 0.14%
- N/a — 0.13%
- N/a — 0.11%
- N/a — 0.08%
- N/a — 0.08%
PRUFX top 10
- Nvidia Corp — 13.49%
- Alphabet Inc Cl A — 11.60%
- Apple Inc — 5.73%
- Broadcom Inc — 5.61%
- Microsoft Corp — 4.07%
- Advanced Micro Devices — 3.79%
- Micron Technology Inc — 3.79%
- Eli Lilly & Co — 3.33%
- Meta Platforms Inc-class A — 3.09%
- Tesla Inc — 2.70%
FAQ
What is the difference between SDAAX and PRUFX?
Which is cheaper, SDAAX or PRUFX?
Should I own both SDAAX and PRUFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.